Get access

Acetylcysteine and carbocysteine for acute respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease

  • Protocol
  • Intervention

Authors

  • YCM Duijvestijn,

  • M Chalumeau,

  • J Smucny,

  • G Pons,

  • G Breart


Ms Yvonne Duijvestijn, Department of Paediatrics (119), Medical Centre Alkmaar, Wilhelminalaan 12, Alkmaar, 1815 JD, NETHERLANDS. yvonneduijvestijn@xs4all.nl.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1. To assess the efficacy of acetylcysteine and carbocysteine as symptomatic treatments for acute respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.

2. To evaluate the safety of acetylcysteine and carbocysteine in the symptomatic treatment of acute respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.

3. To establish a benefit-risk ratio for the use of acetylcysteine and carbocysteine as symptomatic treatments for acute respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.